ELVA Q1 2026 Earnings EPS Surprises to the Upside Stock Advances PRHIZ Q1 2024 Earnings Significant EPS Beat Surprises Markets C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech Alpha Tau Medical DRTS Q1 2026 Earnings Wider Loss Surprises Markets Stock Slips Indaptus Therapeutics Q4 2025 Earnings EPS Misses Estimates on Minimal Revenue Stock Surges